We are live on ! Find out more
QTTB icon

Q32 Bio

52 hedge funds and large institutions have $26.7M invested in Q32 Bio in 2025 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 20 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more capital invested

Capital invested by funds: $16.6M → $26.7M (+$10M)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

2% less funds holding

Funds holding: 5352 (-1)

3.73% less ownership

Funds ownership: 69.1%65.37% (-3.7%)

13% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 8

55% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 20

Holders
52
Holders Change
-1
Holders Change %
-1.89%
% of All Funds
0.63%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
7
Increased
9
Reduced
20
Closed
8
Calls
Puts
Net Calls
Net Calls Change

QTTB Hedge Fund Activity: Q4 2025 in Review

52 of the 8,224 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q4 2025, worth a combined $26.7M — up 60% from $16.6M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of QTTB and 7 opened new positions — a net loss of 1 holder — while 20 trimmed existing stakes and 9 added.

The largest buyer was Opaleye Management, opening a new position worth an estimated $603K. The largest seller was Acorn Capital Advisors, cutting an estimated $876K.

  • 52 institutional investors held Q32 Bio (QTTB) as of Q4 2025, down from 53 in Q3 2025.
  • Funds reported $26.7M of Q32 Bio stock for Q4 2025, up 60% quarter-over-quarter.
  • 7 funds opened new Q32 Bio positions in Q4 2025 and 8 closed out, a net change of -1 holder.
  • The largest Q32 Bio buyer in Q4 2025 was Opaleye Management, an estimated $603K added.
  • The largest Q32 Bio seller in Q4 2025 was Acorn Capital Advisors, an estimated $876K sold.

Based on aggregated 13F filings for Q4 2025.